Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma

Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma – an update

Author:

Kähler Katharina C.¹,Hassel Jessica C.²,Heinzerling Lucie³,Loquai Carmen⁴,Thoms Kai‐Martin⁵,Ugurel Selma⁶^ORCID,Zimmer Lisa⁶,Gutzmer Ralf⁷,

Affiliation:

1. Department of Dermatology Venereology and Allergology University Medical Center of Schleswig‐Holstein Campus Kiel Kiel Germany

2. Department of Dermatology and National Center for Tumor Diseases University Medical Center Heidelberg Germany

3. Department of Dermatology University Medical Center Erlangen Germany

4. Department of Dermatology University Medical Center Mainz Germany

5. Department of Dermatology Venereology and Allergology University Medical Center Göttingen Germany

6. Department of Dermatology Venereology and Allergology University Medical Center Essen Germany

7. Department of Dermatology Venereology and Allergology Skin Cancer Center Hanover Medical School Hanover Germany

Publisher

Wiley

Subject

Dermatology

Link

Reference109 articles.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献